|
[1]Frossard JL.Trypsin activation peptide (TAP) in acute pancreatitis:frompathophysiology to clinical usefulness[J].JOP, 2001, 2 (2) ∶69-77.
|
|
[2]Coelho AM, Machado MC, Cunha JE, et al.Influence of pancreaticenzyme content on experimental acute pancreatitis[J].Pancreas, 2003, 26 (3) ∶230-4.
|
|
[3]Mansfield CS, Jones BR.Plasma and urinary trypsinogen activationpeptide in healthy dogs, dogs with pancreatitis and dogs with othersystemic diseases[J].Aust Vet J, 2000, 78 (6) ∶416-22.
|
|
[4]Neoptolemos JP, Kemppainen EA, Mayer JM, et al.Early predictionofseverity in acute pancreatitis by urinary trypsinogen activation pep-tide:amulticentre study[J].Lancet, 2000, 355 (9219) ∶1955-1960.
|
|
[5]Khan Z, Vlodov J, Horovitz J, et al.Urinary trypsinogen activationpeptide is more accurate than hematocrit in determining severity inpatients with acute pancreatitis:a prospective study[J].Am J Gas-troenterol, 2002, 97 (8) ∶1973-7.
|